Skip Navigation

Cardiovascular Research 2000 47(4):648-657; doi:10.1016/S0008-6363(00)00146-2
© 2000 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Koh, K. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koh, K. K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2000, European Society of Cardiology

Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability

Kwang Kon Koh*

Gachon Medical School, Heart Center, Division of Cardiology, 1198 Kuwol-dong, Namdong-gu, Inchon, 405-760 South Korea

* Corresponding author. Tel.: +82-32-460-3683; fax: +82-32-460-3117 kwangk{at}ghil.com

Clinical trials of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors or statin therapy demonstrate an improvement in cardiovascular end points and coronary stenosis. However, an improvement in cardiovascular end points and coronary stenosis is incompletely explained by the baseline or treated LDL cholesterol level. The beneficial effects of statins on clinical events may involve nonlipid mechanisms that modify endothelial function, smooth muscle cells, and monocyte-macrophage: vasomotor function, inflammatory responses, and plaque stability. Augmented bioactivity of NO by statin therapy either indirectly by its effect on lipoprotein levels and protection of LDL from oxidation, or directly by effects on NO synthesis and release, might account for enhancement of endothelium-dependent vasodilation. Recent experimental and animal studies have demonstrated that statins dose-dependently decrease smooth muscle cells migration and proliferation, independently of their ability to reduce plasma cholesterol. Moreover, statins are able to reduce the in vitro cholesterol accumulation in macrophages and expression of matrix metalloproteinase, resulting in plaque stability. These effects of statins were completely prevented by the addition of mevalonate and partially by all-trans farnesol and all-trans geranylgeraniol, confirming the specific role of isoprenoid metabolites, probably through prenylated proteins, in regulating these cellular events. Statins have been shown to prevent the activation of monocytes into macrophages, inhibit the production of pro-inflammatory cytokines, C-reactive protein, and cellular adhesion molecules. Statins decrease the adhesion of monocyte to endothelial cells. Accordingly, statins exert their cardiovascular benefits through a direct antiatherogenic properties in the arterial wall, beyond their effects on plasma lipids.

KEYWORDS Atherosclerosis; Endothelial function; Infection/inflammation; Statins


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Y. Zhang, J. C. Naggar, C. M. Welzig, D. Beasley, K. S. Moulton, H.-J. Park, and J. B. Galper
Simvastatin Inhibits Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Apolipoprotein E-Knockout Mice: Possible Role of ERK
Arterioscler Thromb Vasc Biol, November 1, 2009; 29(11): 1764 - 1771.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
J. Xu, X. Liu, J. Chen, A. Zacharek, X. Cui, S. Savant-Bhonsale, Z. Liu, and M. Chopp
Simvastatin enhances bone marrow stromal cell differentiation into endothelial cells via notch signaling pathway
Am J Physiol Cell Physiol, March 1, 2009; 296(3): C535 - C543.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. K. Koh, P. C. Oh, and M. J. Quon
Does reversal of oxidative stress and inflammation provide vascular protection?
Cardiovasc Res, March 1, 2009; 81(4): 649 - 659.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. K. Koh, S. M. Park, and M. J. Quon
Leptin and Cardiovascular Disease: Response to Therapeutic Interventions
Circulation, June 24, 2008; 117(25): 3238 - 3249.
[Full Text] [PDF]


Home page
VASC ENDOVASCULAR SURGHome page
K. I. Paraskevas, C. D. Liapis, G. Hamilton, and D. P. Mikhailidis
Are Statins an Option in the Management of Abdominal Aortic Aneurysms?
Vascular and Endovascular Surgery, May 1, 2008; 42(2): 128 - 134.
[Abstract] [PDF]


Home page
PERSPECT VASC SURG ENDOVASC THERHome page
B. A. Perler
Should Statins Be Given Routinely Before Carotid Endarterectomy?
Perspectives in Vascular Surgery and Endovascular Therapy, September 1, 2007; 19(3): 240 - 245.
[Abstract] [PDF]


Home page
IOVSHome page
K. Yamada, E. Sakurai, M. Itaya, S. Yamasaki, and Y. Ogura
Inhibition of Laser-Induced Choroidal Neovascularization by Atorvastatin by Downregulation of Monocyte Chemotactic Protein-1 Synthesis in Mice
Invest. Ophthalmol. Vis. Sci., April 1, 2007; 48(4): 1839 - 1843.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. H. Han, M. J. Quon, J.-a Kim, and K. K. Koh
Adiponectin and Cardiovascular Disease: Response to Therapeutic Interventions
J. Am. Coll. Cardiol., February 6, 2007; 49(5): 531 - 538.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
V. Aboyans, L. Labrousse, P. Lacroix, J. Guilloux, S. Sekkal, A. Le Guyader, E. Cornu, and M. Laskar
Predictive factors of stroke in patients undergoing coronary bypass grafting: statins are protective.
Eur. J. Cardiothorac. Surg., August 1, 2006; 30(2): 300 - 304.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. Kumar, S. Savitz, G. Schlaug, L. Caplan, and M. Selim
Antiplatelets, ACE inhibitors, and statins combination reduces stroke severity and tissue at risk
Neurology, April 25, 2006; 66(8): 1153 - 1158.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. K. Koh and B.-K. Yoon
Controversies regarding hormone therapy: Insights from inflammation and hemostasis
Cardiovasc Res, April 1, 2006; 70(1): 22 - 30.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C.-Y. Wei, K.-C. Huang, Y.-H. Chou, P.-F. Hsieh, K.-H. Lin, and W.-W. Lin
The Role of Rho-Associated Kinase in Differential Regulation by Statins of Interleukin-1beta- and Lipopolysaccharide-Mediated Nuclear Factor {kappa}B Activation and Inducible Nitric-Oxide Synthase Gene Expression in Vascular Smooth Muscle Cells
Mol. Pharmacol., March 1, 2006; 69(3): 960 - 967.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
K. K. Koh, M. J. Quon, S. H. Han, W.-J. Chung, J. Y. Ahn, J.-a Kim, Y. Lee, and E. K. Shin
Additive Beneficial Effects of Fenofibrate Combined With Candesartan in the Treatment of Hypertriglyceridemic Hypertensive Patients
Diabetes Care, February 1, 2006; 29(2): 195 - 201.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Sola, M. Q.S. Mir, S. Lerakis, N. Tandon, and B. V. Khan
Atorvastatin Improves Left Ventricular Systolic Function and Serum Markers of Inflammation in Nonischemic Heart Failure
J. Am. Coll. Cardiol., January 17, 2006; 47(2): 332 - 337.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. K. Koh, S. H. Han, and M. J. Quon
Inflammatory Markers and the Metabolic Syndrome: Insights From Therapeutic Interventions
J. Am. Coll. Cardiol., December 6, 2005; 46(11): 1978 - 1985.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. H. Han, M. J. Quon, and K. K. Koh
Beneficial Vascular and Metabolic Effects of Peroxisome Proliferator-Activated Receptor-{alpha} Activators
Hypertension, November 1, 2005; 46(5): 1086 - 1092.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
P Riboldi, M Gerosa, and P L Meroni
Statins and autoimmune diseases
Lupus, September 1, 2005; 14(9): 765 - 768.
[Abstract] [PDF]


Home page
Eur Heart JHome page
H. Lorenz, C. Junger, K. Seidl, A. Gitt, S. Schneider, R. Schiele, H. Wienbergen, R. Winkler, M. Gottwik, W. Delius, et al.
Do statins influence the prognostic impact of non-sustained ventricular tachycardia after ST-elevation myocardial infarction?
Eur. Heart J., June 1, 2005; 26(11): 1078 - 1085.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. K. Koh, M. J. Quon, S. H. Han, J. Y. Ahn, D. K. Jin, H. S. Kim, D. S. Kim, and E. K. Shin
Vascular and Metabolic Effects of Combined Therapy With Ramipril and Simvastatin in Patients With Type 2 Diabetes
Hypertension, June 1, 2005; 45(6): 1088 - 1093.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Senokuchi, T. Matsumura, M. Sakai, M. Yano, T. Taguchi, T. Matsuo, K. Sonoda, D. Kukidome, K. Imoto, T. Nishikawa, et al.
Statins Suppress Oxidized Low Density Lipoprotein-induced Macrophage Proliferation by Inactivation of the Small G Protein-p38 MAPK Pathway
J. Biol. Chem., February 25, 2005; 280(8): 6627 - 6633.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
A. Tedgui
The role of inflammation in atherothrombosis: implications for clinical practice
Vascular Medicine, February 1, 2005; 10(1): 45 - 53.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Sakamoto, T. Murata, H. Chuma, M. Hori, and H. Ozaki
Fluvastatin Prevents Vascular Hyperplasia by Inhibiting Phenotype Modulation and Proliferation Through Extracellular Signal-Regulated Kinase 1 and 2 and p38 Mitogen-Activated Protein Kinase Inactivation in Organ-Cultured Artery
Arterioscler Thromb Vasc Biol, February 1, 2005; 25(2): 327 - 333.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
D Tousoulis, C Antoniades, E Bosinakou, M Kotsopoulou, C Tsioufis, C Tentolouris, A Trikas, C Pitsavos, and C Stefanadis
Effects of atorvastatin on reactive hyperaemia and the thrombosis-fibrinolysis system in patients with heart failure
Heart, January 1, 2005; 91(1): 27 - 31.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. K. Koh, M. J. Quon, S. H. Han, W.-J. Chung, J. Y. Ahn, Y.-H. Seo, M. H. Kang, T. H. Ahn, I. S. Choi, and E. K. Shin
Additive Beneficial Effects of Losartan Combined With Simvastatin in the Treatment of Hypercholesterolemic, Hypertensive Patients
Circulation, December 14, 2004; 110(24): 3687 - 3692.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
C H Lee, P de Feyter, P W Serruys, F Saia, P A Lemos, D Goedhart, P R Soares, V A W M Umans, M Ciccone, and M Cortellaro
Beneficial effects of fluvastatin following percutaneous coronary intervention in patients with unstable and stable angina: results from the Lescol intervention prevention study (LIPS)
Heart, October 1, 2004; 90(10): 1156 - 1161.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. Z.H. Rittersma, R. J. de Winter, K. T. Koch, C. E. Schotborgh, M. Bax, G. S. Heyde, J. P. van Straalen, K. J. Mulder, J. G.P. Tijssen, G. T. Sanders, et al.
Preprocedural C-Reactive Protein Is Not Associated with Angiographic Restenosis or Target Lesion Revascularization after Coronary Artery Stent Placement
Clin. Chem., September 1, 2004; 50(9): 1589 - 1596.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
L. Tavazzi, G. Tognoni, M. G. Franzosi, R. Latini, A. P. Maggioni, R. Marchioli, G. L. Nicolosi, M. Porcu, and on behalf of the GISSI-HF investigators
Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure
Eur J Heart Fail, August 1, 2004; 6(5): 635 - 641.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. K. Koh, J. W. Son, J. Y. Ahn, D. S. Kim, D. K. Jin, H. S. Kim, S. H. Han, Y.-H. Seo, W.-J. Chung, W. C. Kang, et al.
Simvastatin Combined With Ramipril Treatment in Hypercholesterolemic Patients
Hypertension, August 1, 2004; 44(2): 180 - 185.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. W. Miller, C. D. Tulbert, and D. W. Busija
Rosuvastatin treatment reverses impaired coronary artery vasodilation in fructose-fed, insulin-resistant rats
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2004; 287(1): R157 - R160.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. H. Newman, B. L. Fanburg, S. L. Archer, D. B. Badesch, R. J. Barst, J. G.N. Garcia, P. N. Kao, J. A. Knowles, J. E. Loyd, M. D. McGoon, et al.
Pulmonary Arterial Hypertension: Future Directions: Report of a National Heart, Lung and Blood Institute/Office of Rare Diseases Workshop
Circulation, June 22, 2004; 109(24): 2947 - 2952.
[Full Text] [PDF]


Home page
CirculationHome page
U. Schonbeck and P. Libby
Inflammation, Immunity, and HMG-CoA Reductase Inhibitors: Statins as Antiinflammatory Agents?
Circulation, June 1, 2004; 109(21_suppl_1): II-18 - II-26.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. Y. Streifler
Editorial Comment--Statins, Stroke Outcome, and Stroke Prevention: When Should We Start Treatment?
Stroke, May 1, 2004; 35(5): 1121 - 1123.
[Full Text] [PDF]


Home page
StrokeHome page
J. Marti-Fabregas, M. Gomis, A. Arboix, A. Aleu, J. Pagonabarraga, R. Belvis, D. Cocho, J. Roquer, A. Rodriguez, M. D. Garcia, et al.
Favorable Outcome of Ischemic Stroke in Patients Pretreated with Statins
Stroke, May 1, 2004; 35(5): 1117 - 1121.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
C. R. Wolfram Kuhlmann, C. Gast, F. Li, M. Schafer, H. Tillmanns, B. Waldecker, and J. Wiecha
Cerivastatin Activates Endothelial Calcium-Activated Potassium Channels and Thereby Modulates Endothelial Nitric Oxide Production and Cell Proliferation
J. Am. Soc. Nephrol., April 1, 2004; 15(4): 868 - 875.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. Hakamada-Taguchi, Y. Uehara, K. Kuribayashi, A. Numabe, K. Saito, H. Negoro, T. Fujita, T. Toyo-oka, and T. Kato
Inhibition of Hydroxymethylglutaryl-Coenzyme A Reductase Reduces Th1 Development and Promotes Th2 Development
Circ. Res., November 14, 2003; 93(10): 948 - 956.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. K. Koh, J. Y. Ahn, S. H. Han, D. S. Kim, D. K. Jin, H. S. Kim, M.-S. Shin, T. H. Ahn, I. S. Choi, and E. K. Shin
Pleiotropic effects of angiotensin II receptor blocker in hypertensive patients
J. Am. Coll. Cardiol., September 3, 2003; 42(5): 905 - 910.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. L. Lee, B. R. Wamhoff, L. C. Katwa, H. K. Reddy, D. J. Voelker, J. L. Dixon, and M. Sturek
Increased Endothelin-Induced Ca2+ Signaling, Tyrosine Phosphorylation, and Coronary Artery Disease in Diabetic Dyslipidemic Swine Are Prevented by Atorvastatin
J. Pharmacol. Exp. Ther., July 1, 2003; 306(1): 132 - 140.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Z. Luan, A. J. Chase, and A. C. Newby
Statins Inhibit Secretion of Metalloproteinases-1, -2, -3, and -9 From Vascular Smooth Muscle Cells and Macrophages
Arterioscler Thromb Vasc Biol, May 1, 2003; 23(5): 769 - 775.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
B. W. Fouty and D. M. Rodman
Mevastatin Can Cause G1 Arrest and Induce Apoptosis in Pulmonary Artery Smooth Muscle Cells Through a p27Kip1-Independent Pathway
Circ. Res., March 21, 2003; 92(5): 501 - 509.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
O. Rozenberg, D. M. Shih, and M. Aviram
Human Serum Paraoxonase 1 Decreases Macrophage Cholesterol Biosynthesis: Possible Role for Its Phospholipase-A2-Like Activity and Lysophosphatidylcholine Formation
Arterioscler Thromb Vasc Biol, March 1, 2003; 23(3): 461 - 467.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
T. Nishimura, J. L. Faul, G. J. Berry, L. T. Vaszar, D. Qiu, R. G. Pearl, and P. N. Kao
Simvastatin Attenuates Smooth Muscle Neointimal Proliferation and Pulmonary Hypertension in Rats
Am. J. Respir. Crit. Care Med., November 15, 2002; 166(10): 1403 - 1408.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. H. Wagner, M. Gebauer, B. Guldenzoph, and M. Hecker
3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase-Independent Inhibition of CD40 Expression by Atorvastatin in Human Endothelial Cells
Arterioscler Thromb Vasc Biol, November 1, 2002; 22(11): 1784 - 1789.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Weis, C. L. Schlichting, E. G. Engleman, and J. P. Cooke
Endothelial Determinants of Dendritic Cell Adhesion and Migration: New Implications for Vascular Diseases
Arterioscler Thromb Vasc Biol, November 1, 2002; 22(11): 1817 - 1823.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. L. Dixon, S. Shen, J. P. Vuchetich, E. Wysocka, G. Y. Sun, and M. Sturek
Increased atherosclerosis in diabetic dyslipidemic swine: protection by atorvastatin involves decreased VLDL triglycerides but minimal effects on the lipoprotein profile
J. Lipid Res., October 1, 2002; 43(10): 1618 - 1629.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. K. Koh, J. W. Son, J. Y. Ahn, D. K. Jin, H. S. Kim, Y. M. Choi, D. S. Kim, E.-M. Jeong, G. S. Park, I. S. Choi, et al.
Comparative Effects of Diet and Statin on NO Bioactivity and Matrix Metalloproteinases in Hypercholesterolemic Patients With Coronary Artery Disease
Arterioscler Thromb Vasc Biol, September 1, 2002; 22(9): e19 - 23.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. K. Koh
Effects of estrogen on the vascular wall: vasomotor function and inflammation
Cardiovasc Res, September 1, 2002; 55(4): 714 - 726.
[Full Text] [PDF]


Home page
Eur Heart JHome page
C. Kluft
Is C-reactive protein an additional, surrogate end-point for statin treatment?
Eur. Heart J., May 2, 2002; 23(10): 761 - 764.
[Full Text] [PDF]


Home page
CirculationHome page
M. Weis, C. Heeschen, A. J. Glassford, and J. P. Cooke
Statins Have Biphasic Effects on Angiogenesis
Circulation, February 12, 2002; 105(6): 739 - 745.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Degraeve, M. Bolla, S. Blaie, C. Creminon, I. Quere, P. Boquet, S. Levy-Toledano, J. Bertoglio, and A. Habib
Modulation of COX-2 Expression by Statins in Human Aortic Smooth Muscle Cells. INVOLVEMENT OF GERANYLGERANYLATED PROTEINS
J. Biol. Chem., December 7, 2001; 276(50): 46849 - 46855.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Takemoto and J. K. Liao
Pleiotropic Effects of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors
Arterioscler Thromb Vasc Biol, November 1, 2001; 21(11): 1712 - 1719.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. W.E. van de Poll, T. J. Romer, O. L. Volger, D. J.M. Delsing, T. C. Bakker Schut, H. M.G. Princen, L. M. Havekes, J. W. Jukema, A. van der Laarse, and G. J. Puppels
Raman Spectroscopic Evaluation of the Effects of Diet and Lipid-Lowering Therapy on Atherosclerotic Plaque Development in Mice
Arterioscler Thromb Vasc Biol, October 1, 2001; 21(10): 1630 - 1635.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. J Miller
Emerging mechanisms for secondary cardioprotective effects of statins
Cardiovasc Res, October 1, 2001; 52(1): 5 - 7.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Weis, S. Pehlivanli, B. M. Meiser, and W. von Scheidt
Simvastatin treatment is associated with improvement in coronary endothelial function and decreased cytokine activation in patients after heart transplantation
J. Am. Coll. Cardiol., September 1, 2001; 38(3): 814 - 818.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Diomede, D. Albani, M. Sottocorno, M. B. Donati, M. Bianchi, P. Fruscella, and M. Salmona
In Vivo Anti-Inflammatory Effect of Statins Is Mediated by Nonsterol Mevalonate Products
Arterioscler Thromb Vasc Biol, August 1, 2001; 21(8): 1327 - 1332.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
G. Pasterkamp, A. Vink, C. Borst, T. C. Wascher, A. deCampo, I. Schmoelzer, J. A. Goldstein, C. Grines, and W. W. O'Neill
Multiple Complex Coronary Plaques in Patients with Acute Myocardial Infarction
N. Engl. J. Med., February 15, 2001; 344(7): 527 - 528.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.